Post by IDT Biologika

𝗔𝘀𝗸 𝗼𝘂𝗿 𝗘𝘅𝗽𝗲𝗿𝘁 𝗩𝗼𝗹. 𝟮𝟵 : 𝗪𝗵𝘆 𝗱𝗼 𝘀𝗼 𝗺𝗮𝗻𝘆 𝗮𝗻𝘁𝗶𝗯𝗼𝗱𝘆 𝗽𝗿𝗼𝗴𝗿𝗮𝗺𝘀 𝘀𝘁𝗿𝘂𝗴𝗴𝗹𝗲 𝘄𝗵𝗲𝗻 𝘀𝗰𝗮𝗹𝗶𝗻𝗴 𝘂𝗽? In our Ask our Expert series, Jenna Biedrzycki from IDT Biologika's Business Development, shares what it really takes to move antibody manufacturing from development to reliable GMP production. From upstream consistency to downstream efficiency and regulatory readiness, successful programs are built on more than just a good process. 👉 Get more information in the slider. #AskOurExpert #AntibodyManufacturing #CDMO #Biologics #Biotech #Pharma #GMP #CellCulture #mABs